IPI-549
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for IPI-549, covering 2022-11-25 to 2025-07-25. Get the full timeline:
Most recent: Clinical Trial Update: IPI-549 in Patients With Locally Advanced HPV+ and HPV- Head and Neck Squamous Cell Carcinoma [Phase 2]